The American Thoracic Society (ATS) Presents 10th Annual Free Patient/Family Forum

The American Thoracic Society Public Advisory Roundtable (PAR)

An Interview with Dr. Kristin Highland on Systemic Sclerosis

Dr. Highland is fellowship-trained in both pulmonary/critical care and rheumatology. She is a member of the Respiratory Institute of the Cleveland Clinic Foundation located in Ohio.  Dr. Highland’s research interests have focused on interstitial lung disease and pulmonary hypertension with an emphasis on scleroderma.

Click here to read more >>

Exploring Sources of Emotional Distress among People Living with Scleroderma - A Case Study

The main finding of this case study was that sources of emotional distress for people with scleroderma are multifaceted in nature, begin prior to the diagnosis, and continue throughout their lives in an unpredictable manner. 

Click here to read more >>

Cytori Update on Its U.S. Phase III Scleroderma Trial

Cytori Therapeutics, Inc. announced that its U.S. FDA approved Phase III STAR trial has enrolled and treated its 40^th patient (50% of target enrollment). In addition, a pre-specified independent data monitoring committee review of safety data from the initial 20 patients has been conducted and the committee has recommended that the study continue as planned.

Click here for more >>